Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Haigetang Pharmaceutical is a specialized pharmaceutical company based in Hangzhou, China, and operates as a key subsidiary of the Zhejiang Conba Pharmaceutical Group. The company focuses on the modernization of Traditional Chinese Medicine (TCM) and the production of high-quality chemical drug preparations. Its core product portfolio is centered on respiratory health, featuring the well-known Compound Houttuynia Cordata Mixture used for treating inflammatory conditions of the throat and upper respiratory tract. Haigetang leverages GMP-certified production lines to ensure the safety and efficacy of its botanical-based therapies. The company plays a significant role in the parent group's strategy to dominate the over-the-counter (OTC) and clinical TCM markets in China. It integrates traditional herbal knowledge with modern pharmaceutical technology to serve the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Haigetang Pharmaceutical.